Novartis test drug shows promise in blood cancer
By Anita Greil
The Wall Street Journal Europe
12 Dec 2006
ZURICH—Swiss drug maker Novartis AG said an intermediatestage study showed that its experimental drug Tasigna helped many blood-cancer patients who no longer respond to treatment with its Gleevec drug. Patients in the chronic phase of chronic myeloid... read more...
posted by Bank Report at
1:56 PM
0 Comments:
Post a Comment
<< Home